Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies
about
Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis.Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991.Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar mediaComparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.Antifungal susceptibility testing: practical aspects and current challenges.Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose.Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth.Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis.Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosisEvaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilitiesIn vitro antifungal susceptibility of Cryptococcus gattii.Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.Evaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture mediumIn Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
P2860
Q33710112-47D48F80-AE8A-4E51-BFBB-0F809C906997Q33859215-9426206D-129A-4841-907B-0B508F4E4624Q33960454-BF296C4C-AD55-4829-AAF1-F6E0C09A69CDQ33962343-CE2CFAC7-4750-4389-8EFD-EA8655411768Q33965906-4CB32FAA-58E6-48AC-9CE4-4FCE9176718DQ33969963-0E3D41DF-F493-4E0B-93B3-538D7171426DQ33971884-3A37CBDC-CDC6-4E99-94C0-5295D5597DFAQ33974286-0F48853F-6DEF-43DA-ACDA-1F8FFF60E56CQ33975757-5CB00ECF-0889-48B9-8510-A9EE538AE45EQ33978751-0CC2BAAD-45D9-4613-8937-F5F7A9208136Q33982529-5431719A-C5F7-41B5-A8C8-037D43C5CF48Q33983318-FB9B73F8-B8F1-4139-99E3-114E6736CF29Q34193850-6A1D1ABF-9FD6-4381-A38B-DF342F6160DBQ34518388-0C8A4962-ACBA-4CB4-A9E7-B97E4B4A8869Q34721673-331E359D-12E0-49D3-8EEF-054E9D84B242Q34747071-963E6EFB-1B94-43AB-9D4B-77CB8EC70257Q35004926-5CAF5F97-56A2-4C49-A37F-8605D7CDF32BQ37271714-74450C36-9C3F-4CA6-A633-9DFB56291BB5Q37575561-0B3E8B35-1E41-455B-92A7-6611BDE22287Q39628247-88CB3935-A367-491D-8A07-9382E5C6A769Q42727529-2718FCFE-AE74-47E5-9A77-DCD00089294BQ43111743-1D25DD80-4961-45A6-AC35-68B1558C039D
P2860
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Detection of resistance to amp ...... Standards M27-A methodologies
@ast
Detection of resistance to amp ...... Standards M27-A methodologies
@en
type
label
Detection of resistance to amp ...... Standards M27-A methodologies
@ast
Detection of resistance to amp ...... Standards M27-A methodologies
@en
prefLabel
Detection of resistance to amp ...... Standards M27-A methodologies
@ast
Detection of resistance to amp ...... Standards M27-A methodologies
@en
P2093
P2860
P1476
Detection of resistance to amp ...... Standards M27-A methodologies
@en
P2093
Ghannoum MA
Lozano-Chiu M
Paetznick VL
P2860
P304
P407
P50
P577
1998-10-01T00:00:00Z